Paul Bröckelmann, MD
German Hodgkin Study Group (GHSG)
Department I of Internal Medicine
University Hospital of Cologne
Cologne, Germany
Department I of Internal Medicine
University Hospital of Cologne
Cologne, Germany
Dr. Paul Bröckelmann received his medical training at the University of Cologne, Germany. He completed internships in surgery at Universidad de Buenos Aires – Argentina, Internal Medicine at University Hospital of Cologne – Germany, Internal Medicine at Brighton Sussex Medical School – England, and Psychiatry at University Hospital of Cologne. In addition, he completed the Master Class of the European Hematology Association (EHA). Dr. Bröckelmann is at the Department of Internal Medicine, University Hospital of Cologne, and a trial physician with the German Hodgkin Study Group.
Last modified: November 26, 2018
Authored Items
Where does nivolumab fit in the treatment paradigm for HL?
FAQ published on December 7, 2016
What treatment options exist for HL patients at risk for relapse or disease progression after transplant?
FAQ published on November 2, 2016
How do you identify HL patients at risk for relapse or disease progression after transplant?
FAQ published on October 5, 2016